The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, the reported hemolysis appears to be related to patient conditions.The reported patient effect of hemolysis is listed in the instructions for use as a known possible complication associated with mitraclip procedures.Additionally, the reported test results and hospitalization were a result of case-specific circumstance.There is no indication of a product issue with respect to manufacture, design, or labeling.
|
This is filed to report hemolysis and prolonged hospitalization it was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 4.It was noted that an intra-aortic balloon pump (iabp) was placed prior to the mitraclip procedure.On (b)(6) 2021, two clips (01022u191, 01022u186) were successfully implanted, reducing mr to1.On (b)(6) 2021, after a blood test was performed, the physician stated that the patient possibly developed hemolysis due to elevated lactate dehydrogenase (ldh).It is unknown at this time if the hemolysis is related to the implanted clips or due to an auxiliary circulation by iabp that was previously implanted.The clips remain stable on both leaflets, and mr is 1.Additional treatment was not performed and the patient will remain hospitalized.Additional information was provided.
|